XML 86 R75.htm IDEA: XBRL DOCUMENT v3.26.1
LOSS PER SHARE (Schedule of Outstanding Shares of Common Stock Equivalents were Excluded from the Calculation due to their Antidilutive Nature) (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total shares excluded 14,366,610 13,260,819
Stock-based awards [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total shares excluded 4,547,263 2,191,912
Notes 2025 [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total shares excluded 0 1,249,560
Notes 2029 [Member]    
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]    
Total shares excluded [1] 9,819,347 9,819,347
[1] In conjunction with the issuance of the Notes 2029, in June 2024, the Company used approximately $25,230 of its net proceeds from this offering to pay the cost of the capped call transactions. In July 2024, following a subsequent issuance of the Notes 2029, $3,111 of net proceeds were used to pay the cost of capped call transactions. In accordance with ASC 260 "Earning Per Share", anti dilutive contracts, such as purchased call options, are excluded from the computation of diluted net income (loss) per share. Accordingly, any potential impact resulting from capped call transaction is excluded from the Company's computation of diluted net income (loss) per share.